Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

被引：105

作者：

Furst, D. E. ^{[1
]}

Keystone, E. C. ^{[1
]}

Kirkham, B. ^{[1
]}

Fleischmann, R. ^{[1
]}

Mease, P. ^{[1
]}

Breedveld, F. C. ^{[1
]}

Smolen, J. S. ^{[1
]}

Kalden, J. R. ^{[1
]}

Burmester, G. R. ^{[1
]}

Braun, J. ^{[1
]}

Emery, P. ^{[1
]}

Winthrop, K. ^{[1
]}

Bresnihan, B. ^{[1
]}

De Benedetti, F. ^{[1
]}

Doerner, T. ^{[1
]}

Gibofsky, A. ^{[1
]}

Schiff, M. H. ^{[1
]}

Sieper, J. ^{[1
]}

Singer, N. ^{[1
]}

Van Riel, P. L. C. M. ^{[1
]}

Weinblatt, M. E. ^{[1
]}

Weisman, M. H. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷

关键词：

D O I：

10.1136/ard.2008.100834

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 25

页数：24

共 488 条

[131] Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis [J].

Esteve, M ;

Saro, C ;

González-Huix, F ;

Suarez, F ;

Forné, M ;

Viver, JM .

GUT, 2004, 53 (09) :1363-1365

[132]

ESTRACH C, 2003, ANN SCI M AM COLL RH

[133] Tumour necrosis factor a blocking agents in refractory adult Still's disease: an observational study of 20 cases [J].

Fautrel, B ;

Sibilia, J ;

Mariette, X ;

Combe, B .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :262-266

[134] Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade [J].

Feinstein, J ;

Arroyo, R .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (04) :219-222

[135] Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists [J].

Fernández-Nebro, A ;

Tomero, E ;

Ortiz-Santamaría, V ;

Castro, MC ;

Olivé, A ;

de Haro, M ;

García-Vicuña, R ;

González-Mari, MV ;

Laffón, A ;

García-Vicuña, R .

AMERICAN JOURNAL OF MEDICINE, 2005, 118 (05) :552-556

[136] Rituximab treatment of idiopathic membranous nephropathy [J].

Fervenza, F. C. ;

Cosio, F. G. ;

Erickson, S. B. ;

Specks, U. ;

Herzenberg, A. M. ;

Dillon, J. J. ;

Leung, N. ;

Cohen, I. M. ;

Wochos, D. N. ;

Bergstralh, E. ;

Hladunewich, M. ;

Cattran, D. C. .

KIDNEY INTERNATIONAL, 2008, 73 (01) :117-125

[137] Tumor necrosis factor inhibition and invasive fungal infections [J].

Filler, SG ;

Yeaman, MR ;

Sheppard, DC .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S208-S212

[138] B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents [J].

Finckh, Axel ;

Ciurea, Adrian ;

Brulhart, Laure ;

Kyburz, Diego ;

Moeller, Burkhard ;

Dehler, Silvia ;

Revaz, Sylvie ;

Dudler, Jean ;

Gabay, Cem .

ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1417-1423

[139] Rapid responses to anakinra in patients with refractory adult-onset Still's disease [J].

Fitzgerald, AA ;

LeClercq, SA ;

Yan, A ;

Homik, JE ;

Dinarello, CA .

ARTHRITIS AND RHEUMATISM, 2005, 52 (06) :1794-1803

[140] Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis [J].

Fleischmann, R ;

Stern, R ;

Iqbal, I .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) :1333-1344

← 9 10 11 12 13 14 15 16 17 18 →